These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 57937

  • 1. Immunogenic and immunosuppressive components in soluble preparations from Moloney murine leukemia virus-induced tumor cells.
    Brandchaft PB, Aoki T, Silverman TN.
    Int J Cancer; 1976 May 15; 17(5):678-85. PubMed ID: 57937
    [Abstract] [Full Text] [Related]

  • 2. Cell-mediated immune reaction against tumors induced by oncornaviruses. 3. Studies by mixed lymphocyte-tumor reaction.
    Senik A, Gomard E, Plata F, Levy JP.
    Int J Cancer; 1973 Jul 15; 12(1):233-41. PubMed ID: 4133585
    [No Abstract] [Full Text] [Related]

  • 3. In vitro generation of tumor-specific cytotoxic lymphocytes. Secondary allogeneic mixed tumor lymphocyte culture of normal murine spleen cells.
    Gillis S, Smith KA.
    J Exp Med; 1977 Aug 01; 146(2):468-82. PubMed ID: 69003
    [Abstract] [Full Text] [Related]

  • 4. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK, Ames RS, McIntire RK, Herberman RB.
    Cancer Res; 1979 Dec 01; 39(12):4887-93. PubMed ID: 387218
    [Abstract] [Full Text] [Related]

  • 5. Immunogenicity of subcellular fractions and molecular species of MuLV-induced tumors. III. Stimulation of syngeneic antitumor responses by subcellular fractions and molecular species of Moloney virus-induced tumors in CBA and A mice.
    Ahituv A, Naor D, Sharon R, Tarcic N, Klein BY.
    Cancer Immunol Immunother; 1982 Dec 01; 14(1):16-26. PubMed ID: 6186365
    [Abstract] [Full Text] [Related]

  • 6. Cell-mediated reaction against tumors induced by oncornaviruses. I. Kinetics and specificity of the immune response in murine sarcoma virus (MSV)-induced tumors and transplanted lymphomas.
    Leclerc JC, Gomard E, Levy JP.
    Int J Cancer; 1972 Nov 01; 10(3):589-601. PubMed ID: 4128690
    [No Abstract] [Full Text] [Related]

  • 7. Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus.
    Herberman RB, Aoki T, Nunn M, Lavrin DH, Soares N, Gazdar A, Holden H, Chang KS.
    J Natl Cancer Inst; 1974 Oct 01; 53(4):1103-11. PubMed ID: 4139276
    [No Abstract] [Full Text] [Related]

  • 8. Cell-mediated immunity to moloney sarcoma virus in mice. I. Analysis of antigens responsible for lymphocyte stimulation in regressor mice.
    Knight RA, Gorczynski RM.
    Int J Cancer; 1975 Jan 15; 15(1):48-58. PubMed ID: 47841
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Suppressed development of cytotoxic lymphoid cells in tumor-immunized mice.
    Martin WJ, Wunderlich JR, Macdonald J.
    Isr J Med Sci; 1973 Mar 15; 9(3):324-31. PubMed ID: 4710040
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of a Moloney lymphoma with cyclophosphamide and H-2-incompatible spleen cells.
    Fefer A.
    Cancer Res; 1973 Apr 15; 33(4):641-4. PubMed ID: 4696464
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.